Indirect Acting Carcinogens

Slide 1 · Indirect-acting carcinogens

Metabolic activation, DNA injury and cancer susceptibility

Chemical carcinogenesis • mechanisms and clinicopathologic correlations

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish procarcinogens from ultimate carcinogens.

Trace metabolic activation to DNA injury, initiation and clonal expansion.

Recognize major exposure classes and their cancer associations.

Interpret enzyme polymorphism and mutation signatures critically.

The central question: How does an initially inactive chemical become mutagenic?

Slide 3 · Chemical carcinogenesis is a multistep process

Chemical exposure

DNA injury / initiation

Expansion of initiated cells

Additional alterations

Malignant clone

A single exposure need not produce a fully malignant tumor.

Initiation and promotion are mechanistically different events.

Slide 4 · Pott’s observation linked soot to cancer

Sir Percival Pott linked scrotal skin cancer in chimney sweeps to soot exposure.

The association preceded modern identification of specific carcinogenic molecules.

It illustrates how occupational observation can implicate environmental carcinogens.

Historical inference

Exposure pattern

→ elevated cancer occurrence

→ etiologic hypothesis

Slide 5 · Chemical initiators fall into two activation classes

Direct-acting

Chemically active without metabolic conversion

Includes several alkylating agents

Can damage DNA directly

Indirect-acting

Requires endogenous metabolic conversion

Initial substance is a procarcinogen

The reactive product is the ultimate carcinogen

Slide 6 · Metabolic conversion defines indirect carcinogens

Procarcinogen ≠ ultimate carcinogen

Procarcinogen: Precursor that requires activation

Ultimate carcinogen: Active product capable of initiating damage

Conversion is commonly mediated by host metabolic enzymes

Slide 7 · A procarcinogen becomes dangerous after activation

Exposure to precursor

Uptake / tissue exposure

Metabolic activation

Reactive ultimate carcinogen

Interaction with DNA

The active form—not merely the parent exposure—is pivotal to initiation.

Slide 8 · Direct and indirect agents converge on DNA injury

Chemical carcinogens

Direct-acting

No conversion needed

Indirect-acting

Metabolic activation needed

Reactive carcinogenic species → DNA damage

Slide 9 · Not every exposed cell becomes malignant

Carcinogens initiate through genetic injury; A malignant phenotype requires further alterations.

DNA repair, persistence of mutation and subsequent proliferation influence outcome.

The textbook separates initiation from the promotional expansion of an altered clone.

Exposure is the start of a sequence, not an automatic cancer diagnosis.

Slide 10 · Initiation creates heritable genetic change

Initiating chemical

Nonlethal DNA damage

Mutation becomes fixed

Altered daughter-cell clone

Initiation involves permanent genetic change, not simply temporary chemical exposure.

Slide 11 · Electrophiles are the reactive initiating species

Chemical initiators are reactive electrophiles: They contain electron-deficient atoms.

Electrophiles interact with nucleophilic, electron-rich sites in cells.

DNA is a critical molecular target because permanent mutations drive transformation.

Chemical interaction

Electron-poor electrophile

↓ reaction

Electron-rich cellular target

Slide 12 · DNA provides nucleophilic molecular targets

Schematic: Reactive electrophile encounters DNA

Reactive electrophile

Reactive chemicals may form covalent lesions at susceptible DNA sites.

The relevant carcinogenic effect is an altered DNA sequence after inaccurate repair or replication.

A lesion is not equivalent to a permanently established mutation.

Slide 13 · DNA injury has more than one outcome

DNA lesion after exposure

Effective correction

Sequence maintained

Misrepair / replication

Mutation fixed

Only fixed mutations can be inherited by descendant cells

Slide 14 · An initiated cell can appear viable

Initiating damage is described as nonlethal in the classic model.

The cell survives to transmit the altered DNA sequence to progeny.

The resulting clone may remain clinically silent until further progression.

Initiation concerns molecular inheritance, not a recognizable tumor mass.

Slide 15 · Mutation fixation makes initiation persistent

Reactive species

DNA damage

Error-prone processing

Stable mutant genome

Clonal inheritance

Removal of the external exposure does not undo an already fixed mutation.

Slide 16 · Promotion expands initiated cells

Previously initiated cell

Proliferative stimulus

Clonal expansion

Further genetic change

Progressing neoplasm

Promotion is not synonymous with an independent DNA-mutating exposure.

Slide 17 · Initiator and promoter play distinct roles

Feature

Initiating agent

Promoting influence

Primary action

Induces permanent genetic change

Stimulates proliferation

DNA mutation

Central to initiation

Not required for its defining role

Alone in classic model

Can initiate altered cells

Not tumorigenic alone

Effect on clone

Creates altered founder

Expands initiated descendants

Slide 18 · The sequence of events explains experimental tumors

Classic mouse-skin studies distinguished initiation from promotion.

Promoters produce tumors by stimulating already initiated cells.

Clonal expansion raises opportunity for additional genetic alterations.

Conceptual order

Initiate

→ Promote

→ Progress

Slide 19 · Promoters can be physiologic or inflammatory

Hormonal proliferation

Unopposed estrogenic stimulation

Endometrial and breast tissue

Illustrates growth-promoting context

Chronic tissue repair

Persistent inflammation or fibrosis

Examples include chronic hepatitis and inflammatory bowel disease

Repeated cycles of injury and repair

Slide 20 · A cancer needs cumulative alterations

Mutated founder

Expanded premalignant clone

Subclones acquire changes

Selection of advantageous clones

Malignancy

The multistep model explains the interval between exposure and cancer emergence.

Slide 21 · Major procarcinogen classes are chemically diverse

Class in Robbins

Illustrative agents

Common teaching context

Polycyclic / heterocyclic aromatic hydrocarbons

Benzo[a]pyrene; benz[a]anthracene

Combustion-related exposure

Aromatic amines, amides, azo dyes

2-naphthylamine; benzidine

Historical occupational exposure

Plant / microbial products

Aflatoxin B₁; safrole; cycasin

Natural-source exposures

Other listed agents

Nitrosamines; vinyl chloride; PCBs

Environment / industry / food chemistry

Slide 22 · Polycyclic aromatic hydrocarbons are potent procarcinogens

Polycyclic hydrocarbons among the most potent indirect chemical carcinogens.

They occur in fossil-fuel products and combustion-derived material.

A prominent teaching example is benzo[a]pyrene.

Chemical class links sources, metabolic activation and DNA damage.

Slide 23 · Soot and fossil fuels are exposure reservoirs

Polycyclic hydrocarbons are present in fossil fuels.

Soot provided a historically important exposure signal in chimney sweeps.

The carcinogenic effect depends on constituent chemicals, not the descriptive term “soot” alone.

Exposure pathway

Fuel / carbon material

→ contaminated mixture

→ human contact

Slide 24 · Tobacco combustion produces carcinogenic hydrocarbons

Tobacco combustion

Polycyclic hydrocarbons

Metabolic activation

DNA injury

Lung-cancer risk

Benzo[a]pyrene is one example of a smoke-associated chemical carcinogen.

Slide 25 · Benzo[a]pyrene is a model indirect carcinogen

Produced during high-temperature combustion, including tobacco burning.

Belongs to the polycyclic aromatic hydrocarbon class.

Requires conversion by metabolic enzymes to a reactive carcinogenic form.

Model teaching chain

Benzo[a]pyrene

→ P450-mediated activation

→ DNA-reactive metabolites

Slide 26 · Combustion exposures span several environments

Inhalational settings

Cigarette smoke

Soot and combustion products

Historical occupational contact

Dietary settings

Broiled or grilled meat

Smoked meat

Smoked fish

Slide 27 · High-temperature cooking can generate hydrocarbons

Animal-fat-containing food

High-temperature broiling / grilling

Polycyclic hydrocarbon formation

Dietary exposure

Robbins also identifies smoked meats and fish as sources.

Slide 28 · Exposure source is not equal to dose or individual risk

Identifying a source establishes a possible exposure pathway.

Actual carcinogenic risk also depends on the amount and pattern of exposure.

Metabolic activation, inactivation and later biologic events modify outcome.

Do not equate the presence of a named carcinogen with inevitable malignancy.

Slide 29 · Aromatic amines and azo dyes form another major class

These chemicals are identified as indirect-acting carcinogens.

Historically used extensively in aniline-dye and rubber industries.

Examples listed include 2-naphthylamine, benzidine and dimethylaminoazobenzene.

An industrial exposure history can provide etiologic clues.

Slide 30 · Historical industries illustrate occupational risk

Industrial chemical use

Worker exposure

Host metabolism

Reactive intermediates

Potential mutagenesis

The pathway is conceptual; Individual agents and occupational conditions vary.

Slide 31 · Representative aromatic compounds are not interchangeable

Agent named by Robbins

Table 7.10 category

Important interpretation

2-Naphthylamine

Aromatic amine

Specified chemical; do not substitute a generic dye

Benzidine

Aromatic amine

Distinct agent within the same broad class

2-Acetylaminofluorene

Aromatic amide

Listed among activation-dependent compounds

Dimethylaminoazobenzene

Azo dye

Also called “butter yellow”

Slide 32 · Aflatoxin B₁ is a natural-source carcinogen

Aflatoxin B₁ as a carcinogen from certain strains of Aspergillus.

This illustrates that “natural” exposure is not synonymous with biologic safety.

The clinically relevant tumor association in the text is hepatocellular carcinoma.

The example also demonstrates an exposure-linked mutation hotspot.

Slide 33 · Improper grain and nut storage permits fungal growth

Improperly stored grains / nuts

Growth of Aspergillus

Food contamination with aflatoxin

Dietary exposure

The exposure pathway precedes the molecular events in hepatic cells.

Slide 34 · Aflatoxin exposure has a geographic association

Strong correlation between dietary aflatoxin contamination and hepatocellular carcinoma in parts of Africa and Asia.

This is an epidemiologic association described.

Regional patterns should not be misconstrued as uniform individual exposure.

Observed relationship

Contaminated food

→ dietary exposure

→ associated HCC incidence

Slide 35 · Aflatoxin-linked cancers can show TP53 hotspots

Aflatoxin exposure

DNA sequence-specific damage

Selection / mutation fixation

TP53 codon 249 hotspot

Impaired p53 function

This is an association and mechanistic illustration, not a universal diagnostic criterion.

Slide 36 · TP53 codon 249 exemplifies a point mutation

G:C → T:A transversion

Codon 249 is a characteristic hotspot in aflatoxin-associated HCC.

The resulting amino-acid substitution is Arg → Ser (R249S).

The variant compromises p53 tumor-suppressor function.

Slide 37 · A hotspot is enrichment, not exclusivity

What hotspot means

A recurrently affected genomic position

Preferential chemical / sequence interaction

An enriched lesion in exposed tumors

What it does not mean

All exposed people carry the mutation

Every HCC has the substitution

A single mutation proves the exposure history

Slide 38 · The mutation pattern differs by exposure context

Setting described in Robbins

TP53 codon 249 observation

Aflatoxin-associated HCC

Characteristic hotspot reported

Liver tumors from areas without aflatoxin contamination

TP53 mutations less frequent; few at codon 249

Interpretive boundary

An association, not a standalone clinical test

Slide 39 · Most chemical initiating agents target DNA

Mutagenicity follows from the fact that malignant transformation depends on genetic alterations.

DNA is the major target of chemical initiators.

Initiation does not depend on one exclusive carcinogen-specific cancer gene.

Damage can occur broadly; Selection determines which mutant cells expand.

Slide 40 · A DNA lesion and a driver mutation are different

DNA lesion / mutation

Chemical interaction may damage many sites

Many mutations have little selective effect

Mutational patterns reflect exposure chemistry

Selected driver alteration

Provides a growth or survival advantage

May involve an oncogene or tumor suppressor

Can contribute to stepwise progression

Slide 41 · Mutations are distributed but not chemically uniform

Reactive chemical interacts with DNA

Numerous genomic sites

Mutations may be widespread

Preferred bases / sequences

Hotspots and characteristic substitutions

Selection expands clones with biologic advantage

Slide 42 · RAS and TP53 illustrate selection after mutation

Carcinogen-induced changes are not restricted to one specific cancer gene.

Cells that acquire advantageous alterations may clonally expand.

RAS and TP53 as illustrative oncogene and tumor-suppressor targets.

Evolutionary logic

Mutation occurs

→ selective advantage

→ expansion of clone

Slide 43 · DNA chemistry can bias substitution patterns

Chemical structure

Preferred DNA interactions

Characteristic DNA lesions

Enriched base substitutions

Exposure-associated pattern

Mutations need not occur at uniformly random DNA positions.

Slide 44 · Smoking-associated lung cancers carry greater mutational burden

≈10-fold greater average mutational burden

Smoking-associated lung cancers with lung cancers in nonsmokers.

The excess includes substitutions associated with tobacco-smoke carcinogens.

This is a tumor-group average reported in the supplied text, not a patient-level cutoff.

Slide 45 · Tobacco produces a recognizable substitution bias

Smoke carcinogens

DNA injury

Characteristic base substitutions

Tumor genome

Exposure-associated signature

Mutational burden and mutational spectrum provide different kinds of information.

Slide 46 · Mutational burden and signature answer different questions

Genomic observation

Interpretive question

Robbins example

Mutational burden

How many alterations occur?

Higher average burden in smoking-related lung cancer

Substitution spectrum

What kinds of nucleotide changes?

Smoking-associated base substitutions

Hotspot

Which site recurs?

TP53 codon 249 in aflatoxin-associated HCC

Slide 47 · A mutational signature is a pattern, not a diagnosis

Cancer genome sequencing identifies characteristic combinations of mutations.

Some patterns can be associated with specific carcinogenic exposures.

Pattern recognition alone does not establish every individual exposure or cause.

Use genomic findings alongside epidemiology and exposure history.

Slide 48 · Not every mutational signature has a known cause

Dozens of mutational signatures have been described.

Some signatures reflect exposure to chemotherapeutic agents.

Many remain unexplained; A proposed causal exposure requires further evidence.

Scientific interpretation

Recognized pattern

≠

Proven single exposure

Slide 49 · Cytochrome P450 activates many procarcinogens

Indirect carcinogen

Cytochrome P450 monooxygenase

Metabolically reactive product

DNA interaction

Most indirect carcinogens are described as requiring P450-dependent metabolism.

Slide 50 · Metabolic enzymes are endogenous host factors

The activating enzymes are produced by the exposed individual.

Their genes influence how efficiently a precursor is converted.

Thus, the same external exposure can have biologically different consequences.

Susceptibility partly reflects the interaction of exposure and metabolism.

Slide 51 · P450 enzyme genes are polymorphic

Different allelic variants can encode different enzyme activity or inducibility.

These inherited differences are identified as one determinant of carcinogenesis susceptibility.

A gene variant modifies risk; It does not independently establish cancer.

Risk modifiers

Inherited enzyme variant

→ activation capacity

→ reactive metabolite load

Slide 52 · Inducibility and basal activity are not identical

Enzyme activity

Catalytic behavior at a given state

Affects conversion of procarcinogen

May vary among individuals

Enzyme inducibility

Capacity to increase enzyme expression / activity

Can alter conversion following exposure

Also subject to genetic variation

Slide 53 · CYP1A1 illustrates activation of benzo[a]pyrene

Benzo[a]pyrene

CYP1A1-mediated metabolism

Activated reactive species

DNA injury / mutation risk

This is the specific P450 example used by Robbins.

Slide 54 · A high-inducibility CYP1A1 variant

Inherited CYP1A1 variability affects activation potential

Textbook example: ~10% of people of Northern European descent have a highly inducible form.

Up to sevenfold higher lung-cancer risk in smokers with this genotype versus smokers without it.

These are source-reported population associations, not universal predictive estimates.

Slide 55 · Activation and detoxification are competing fates

Procarcinogen / reactive metabolite

Activation pathways

Formation of DNA-reactive products

Inactivation pathways

Metabolic detoxification

Net biologically effective carcinogen burden varies

Slide 56 · Variation in detoxification can modify risk

Metabolism can inactivate a precursor or derivative, not merely activate it.

Differences in these pathways can change the amount of damaging metabolite present.

Risk depends on the balance between generation and removal of active species.

Two-way metabolism

Activation ↑ → injury potential ↑

Detoxification ↑ → burden ↓

Slide 57 · Cancer susceptibility cannot be read from one gene

Chemical exposure, activating enzymes and detoxifying pathways all matter.

DNA repair and the proliferation of initiated cells are additional steps in the model.

Genetic predisposition is probabilistic; The source does not establish a clinical predictive test.

Avoid deterministic language when interpreting metabolic polymorphisms.

Slide 58 · Other environmental agents appear’ table

Source grouping

Selected entries listed

Other occupational / environmental

Vinyl chloride; nickel; chromium

Additional chemical concerns

Pesticides; polychlorinated biphenyls

Natural products

Griseofulvin; cycasin; safrole; betel nuts

Food-related chemistry

Nitrosamines / related amides

Slide 59 · Food nitrites can participate in nitrosamine formation

Nitrite in food preservation

Reaction with food amines

Nitrosamine formation

Potential carcinogenic concern

Nitrosamines formed this way as suspected carcinogens; Do not imply quantified dietary risk.

Slide 60 · Exposure history organizes clinicopathologic reasoning

Exposure inquiry

Tobacco and combustion products

Occupation / industrial chemicals

Food storage and dietary contamination

Biologic interpretation

Possible metabolic activation

Potential DNA damage signature

Context of tumor type and host factors

Slide 61 · Case: Cigarette-smoke exposure

A patient with lung cancer has a prolonged smoking history. A tumor sequencing report shows many base substitutions.

Discussion prompts

What feature of smoke connects exposure to DNA damage?

Why does the mutation spectrum complement—but not replace—the exposure history?

High-temperature combustion generates indirect chemical carcinogens, including benzo[a]pyrene. Activation and characteristic DNA substitutions may leave an exposure-associated signature.

Slide 62 · Case: Grain storage and hepatocellular carcinoma

A region with frequent food contamination from improperly stored grains has increased hepatocellular carcinoma incidence.

Discussion prompts

Which natural-source carcinogen is?

Which tumor-suppressor hotspot is classically associated?

Aflatoxin B₁ produced by certain Aspergillus strains. TP53 codon 249 G:C → T:A transversion with R249S substitution.

Slide 63 · Case: Genetically variable metabolism

Two smokers report comparable tobacco exposure but differ in genetically determined P450 inducibility.

Discussion prompts

Can exposure be translated into identical amounts of ultimate carcinogen?

What additional metabolic fate must be considered?

No. Activation rates may vary with enzyme polymorphisms and inducibility. Inactivation / detoxification pathways also influence net metabolite burden.

Slide 64 · Compare three representative examples

Example

Exposure setting

Molecular teaching point

Benzo[a]pyrene

Tobacco / soot / combustion

P450 bioactivation; tobacco-linked mutation patterns

Aflatoxin B₁

Contaminated food

Association with TP53 codon 249 hotspot

Aromatic amines / azo dyes

Historical dye and rubber industry

Occupational procarcinogens needing activation

Slide 65 · A defensible causal chain has several links

Chemical source

Host metabolic activation

DNA injury and mutation

Expansion / selection

Cancer emergence

Each link should be supported separately when interpreting a real patient or population.

Slide 66 · Five distinctions prevent common errors

Procarcinogen is not the same as its ultimate carcinogen.

Chemical initiation is not the same as proliferative promotion.

DNA lesions are not identical to permanently fixed mutations.

Mutation signatures are not always a unique proof of exposure.

Metabolic susceptibility does not make malignancy inevitable.

Mechanism, exposure, genome and clonal evolution must be interpreted together.

Slide 67 · Primary reading

Robbins, Cotran & Kumar: Pathologic Basis of Disease.

11th edition (2026).

Sections: Chemical Carcinogenesis; Indirect-Acting Carcinogens; Molecular Targets of Chemical Carcinogens.

Conceptual figures and teaching diagrams in this lecture are newly constructed, not reproduced textbook images.